DeepMed Research

Vinmec Research Institute of Stem Cell and Gene Technology

🇻🇳Vietnam

Country: 🇻🇳Vietnam

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Autologous BMMNCs Combined With Educational Intervention for ASD

Phase 2

Completed

Conditions: Autism Spectrum Disorder

Interventions: Combination Product: Educational intervention
Combination Product: Autologous BMMNCs transplantation and educational intervention

First Posted Date: 2022-04-01

Last Posted Date: 2024-06-04

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 54

Registration Number: NCT05307536

Locations: 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae

Phase 1

Completed

Conditions: Sequelae of Injuries of Head

Interventions: Biological: autologous bone marrow-derived mononuclear cell transplantation
Other: Rehabilitation therapy

First Posted Date: 2022-03-24

Last Posted Date: 2024-10-01

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 50

Registration Number: NCT05293873

Locations: 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke

Phase 1

Completed

Conditions: Ischemic Stroke

Interventions: Other: standard stroke treatment and rehabilitation therapy
Biological: UC-MSC infusion via intrathecal route
Biological: UC-MSC infusion via intravenous route

First Posted Date: 2022-03-23

Last Posted Date: 2025-01-06

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 48

Registration Number: NCT05292625

Locations: 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty

Phase 1

Active, not recruiting

Conditions: Frailty

Interventions: Biological: Umbilical Cord Mesenchymal Stem Cells transplantation
Drug: standard frailty treatment and supplementary medication

First Posted Date: 2021-06-09

Last Posted Date: 2024-06-06

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 158

Registration Number: NCT04919135

Locations: 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia

Phase 1

Completed

Conditions: Primary Biliary Cirrhosis

Interventions: Biological: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation

First Posted Date: 2020-08-21

Last Posted Date: 2024-06-06

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 20

Registration Number: NCT04522869

Locations: 🇻🇳
Vinmec International Hospital Times City, Hà Nội, Hanoi, Vietnam
🇻🇳
Vinmec Research Institute of Stem cell and Gene Technology, Hanoi, Vietnam

Convalescent Plasma for COVID-19 Patients (CPCP)

Phase 1

Completed

Conditions: COVID 19

Interventions: Biological: Convalescent Plasma as Therapy for Covid-19 patients

First Posted Date: 2020-08-20

Last Posted Date: 2024-06-05

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 4

Registration Number: NCT04521036

Locations: 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Convalescent Plasma for COVID-19 Patients

Early Phase 1

Completed

Conditions: COVID 19

Interventions: Biological: Convalescent COVID 19 Plasma

First Posted Date: 2020-08-18

Last Posted Date: 2024-06-06

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 4

Registration Number: NCT04516954

Locations: 🇻🇳
Vinmec Research Institute of Stem cell and Gene Technology, Hanoi, Vietnam

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

Phase 1

Completed

Conditions: COPD

Interventions: Biological: Umbilical Cord Mesenchymal Stem Cells transplantation
Drug: drug therapy according to Vietnamese MOHS procedure

First Posted Date: 2020-06-16

Last Posted Date: 2024-06-04

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 40

Registration Number: NCT04433104

Locations: 🇻🇳
Vinmec International Hospital Times City, Hà Nội, Hanoi, Vietnam

Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis

Phase 1

Completed

Conditions: Encephalitis
Meningitis

Interventions: Combination Product: Stem cell transplantation

First Posted Date: 2019-09-06

Last Posted Date: 2024-06-06

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 22

Registration Number: NCT04080921

Locations: 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia

Phase 1

Completed

Conditions: Bronchopulmonary Dysplasia

Interventions: Combination Product: stem cell transplantation

First Posted Date: 2019-08-20

Last Posted Date: 2024-06-04

Lead Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology

Target Recruit Count: 10

Registration Number: NCT04062136

Locations: 🇻🇳
Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy